aloxistatin has been researched along with Myelodysplastic Syndromes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hishita, T; Kawanishi, S; Miura, Y; Nishihara, T; Tada-Oikawa, S; Tohyama, K; Tohyama, Y; Uchiyama, T; Yoshida, Y | 1 |
1 other study(ies) available for aloxistatin and Myelodysplastic Syndromes
Article | Year |
---|---|
Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39.
Topics: Anti-Bacterial Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cathepsin L; Cathepsins; Cell Line; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Cytochrome c Group; Endopeptidases; Enzyme Activation; Enzyme Inhibitors; Etoposide; Humans; Hydrogen-Ion Concentration; Intracellular Membranes; Leucine; Lysosomes; Macrolides; Membrane Potentials; Mitochondria; Myelodysplastic Syndromes; Proton-Translocating ATPases; Vacuolar Proton-Translocating ATPases | 2001 |